| Mr Mendel Alidio Uychutin, OTR/L | |
|
1755 W Hammer Ln, Suite#1, Stockton, CA 95209-2900 | |
| (209) 462-1598 | |
| (209) 942-0294 |
| Full Name | Mr Mendel Alidio Uychutin |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 1755 W Hammer Ln, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336445345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2330 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mendel Alidio Uychutin, OTR/L 1755 W Hammer Ln, Suite#1, Stockton, CA 95209-2900 Ph: (209) 462-1598 | Mr Mendel Alidio Uychutin, OTR/L 1755 W Hammer Ln, Suite#1, Stockton, CA 95209-2900 Ph: (209) 462-1598 |
News Archive
A public and scientific discussion is currently taking place focusing on the question whether substances at low concentrations may lead to health impairments in humans. For this reason, an increasing number of experimental studies to test such effects are currently conducted using different chemicals.
The Adler School of Professional Psychology has received a $25,000 grant from the Robert Wood Johnson Foundation to support the Annual Conference of the Institute on Social Exclusion. This year's conference, titled "The Social Determinants of Mental Health: from Awareness to Action," will be the first ever in the United States to convene innovative thinkers from diverse disciplinary backgrounds to address this topic, and has already received international interest.
Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest and Tamoxitest. These tests and the GeneMedRx medication management software can save lives and healthcare dollars by allowing doctors to personalize their prescribing practices in order to prevent adverse medication outcomes, including treatment failures and dangerous side effects.
Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.
› Verified 1 days ago
John Maglasang, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9107 Davis Rd, Stockton, CA 95209 Phone: 209-478-6488 | |
Ronald I Mil, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5320 Carrington Cir, Stockton, CA 95210 Phone: 209-473-3004 Fax: 209-473-4059 | |
Rainier Restie Javier, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 537 E Fulton St, Stockton, CA 95204 Phone: 209-466-2066 | |
Derek Thomas Alday Robinson, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 534 E Pine St, Suite A, Stockton, CA 95204 Phone: 209-463-5800 Fax: 209-463-5900 | |
Mr. Stephen James Lofy, OTR, HTC, PAM, SWC Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9107 Davis Rd, Stockton, CA 95209 Phone: 209-478-6488 Fax: 209-478-3916 | |
Cheryl Spaulding, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Macduff Ave, Stockton, CA 95210 Phone: 209-478-4848 | |
Martha Sakakura, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1319 N Madison St, Stockton, CA 95202 Phone: 209-996-1037 |